Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline.

导出原文传递

翻译打印收藏纠错

作者： N Lynn,Henry ^[1] ; Mark R,Somerfield ^[2] ; Vandana G,Abramson ^[3] ; Nofisat,Ismaila ^[2] ; Kimberly H,Allison ^[4] ; Carey K,Anders ^[5] ; Diana T,Chingos ^[6] ; Andrea,Eisen ^[7] ; Bruno L,Ferrari ^[8] ; Thomas H,Openshaw ^[9] ; Patricia A,Spears ^[5] ; Praveen,Vikas ^[10] ; Vered,Stearns ^[11]

作者单位： 1University of Utah Huntsman Cancer Institute, Salt Lake City, UT. ^[1] 2American Society of Clinical Oncology, Alexandria, VA. ^[2] 3Vanderbilt-Ingram Cancer Center, Nashville, TN. ^[3] 4Stanford University Medical Center, Stanford, CA. ^[4] 5University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC. ^[5] 6Patient Advocate in Research, Los Angeles, CA. ^[6] 7Sunnybrook Odette Cancer Centre, Cancer Care Ontario, Toronto, Canada. ^[7] 8Oncoclinicas Group, São Paulo, Brazil. ^[8] 9Northern Light Cancer Institute, Brewer, ME. ^[9] 10University of Iowa Holden Comprehensive Cancer Center, Iowa City, IA. ^[10] 11Kimmel Cancer Center at Johns Hopkins, Baltimore, MD. ^[11]